' Eagerly Awaited ' Results of CANVAS ' Eagerly Awaited ' Results of CANVAS

Do SGLT-2 inhibitors reduce the risk for major cardiovascular events? Dr Wysham discusses hot-off-the-press results of the CANVAS program at ADA 2017.Endocrine Society

Source: Medscape Today Headlines - June 21, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Commentary Source Type: news